PP
ANAC

PDT Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

PDT Partners’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-48,125
Closed -$5.67M – 1315
2015
Q3 		$5.67M Buy
48,125
+278
+0.6% +$36.3K 0.13% 203
2015
Q2 		$3.71M Buy
+47,847
New +$3.14M 0.1% 263

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PDT Partners's ANAC Position: Q4 2015 in Review

PDT Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 48,125 shares — an estimated $5.67M sold.

PDT Partners first reported a position in ANAC in Q2 2015 and held it in 2 quarters. The position peaked at $5.67M in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • PDT Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 48,125 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $5.67M.
  • PDT Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 2 quarters.
  • PDT Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $5.67M in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.